Alpha fetoprotein (AFP) is the most important used and accepted serum predictive biomarker of hepatocellular carcinoma (HCC), with 20 ng/mL for HCC screening and diagnosis or 200 and/or 400 ng/mL for treatment stratification [71]. This evidence concerns the gene AFP and hepatocellular carcinoma.